Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
This study is enrolling participants by invitation only.
Study NCT00886262   Information provided by Medical University of South Carolina

First Received on April 21, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Failure
More general conditions related to this trial
Digestive System Diseases
Hepatic Insufficiency
Liver Diseases
Interventions listed in this trial
Vasopressin
Normal saline placebo
Additional drug interventions recognized in this trial
Arginine Vasopressin
Vasopressins
More general drug interventions related to this trial
Antidiuretic Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Medical University of South Carolina
Emory University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services